Cargando…

The pharmacology and therapeutic potential of (−)-huperzine A

(−)-Huperzine A (1) is an alkaloid isolated from a Chinese club moss. Due to its potent neuroprotective activities, it has been investigated as a candidate for the treatment of neurodegenerative diseases, including Alzheimer’s disease. In this review, we will discuss the pharmacology and therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Tun, Maung Kyaw Moe, Herzon, Seth B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863551/
https://www.ncbi.nlm.nih.gov/pubmed/27186124
http://dx.doi.org/10.2147/JEP.S27084
_version_ 1782431498091102208
author Tun, Maung Kyaw Moe
Herzon, Seth B
author_facet Tun, Maung Kyaw Moe
Herzon, Seth B
author_sort Tun, Maung Kyaw Moe
collection PubMed
description (−)-Huperzine A (1) is an alkaloid isolated from a Chinese club moss. Due to its potent neuroprotective activities, it has been investigated as a candidate for the treatment of neurodegenerative diseases, including Alzheimer’s disease. In this review, we will discuss the pharmacology and therapeutic potential of (−)-huperzine A (1). Synthetic studies of (−)-huperzine A (1) aimed at enabling its development as a pharmaceutical will be described.
format Online
Article
Text
id pubmed-4863551
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-48635512016-05-16 The pharmacology and therapeutic potential of (−)-huperzine A Tun, Maung Kyaw Moe Herzon, Seth B J Exp Pharmacol Review (−)-Huperzine A (1) is an alkaloid isolated from a Chinese club moss. Due to its potent neuroprotective activities, it has been investigated as a candidate for the treatment of neurodegenerative diseases, including Alzheimer’s disease. In this review, we will discuss the pharmacology and therapeutic potential of (−)-huperzine A (1). Synthetic studies of (−)-huperzine A (1) aimed at enabling its development as a pharmaceutical will be described. Dove Medical Press 2012-09-05 /pmc/articles/PMC4863551/ /pubmed/27186124 http://dx.doi.org/10.2147/JEP.S27084 Text en © 2012 Tun and Herzon, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Tun, Maung Kyaw Moe
Herzon, Seth B
The pharmacology and therapeutic potential of (−)-huperzine A
title The pharmacology and therapeutic potential of (−)-huperzine A
title_full The pharmacology and therapeutic potential of (−)-huperzine A
title_fullStr The pharmacology and therapeutic potential of (−)-huperzine A
title_full_unstemmed The pharmacology and therapeutic potential of (−)-huperzine A
title_short The pharmacology and therapeutic potential of (−)-huperzine A
title_sort pharmacology and therapeutic potential of (−)-huperzine a
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863551/
https://www.ncbi.nlm.nih.gov/pubmed/27186124
http://dx.doi.org/10.2147/JEP.S27084
work_keys_str_mv AT tunmaungkyawmoe thepharmacologyandtherapeuticpotentialofhuperzinea
AT herzonsethb thepharmacologyandtherapeuticpotentialofhuperzinea
AT tunmaungkyawmoe pharmacologyandtherapeuticpotentialofhuperzinea
AT herzonsethb pharmacologyandtherapeuticpotentialofhuperzinea